| Name | Title | Contact Details |
|---|---|---|
Felix Mercado |
Chief Financial Officer | Profile |
Celyad is a clinical-stage biopharmaceutical company focused on the identification and development of specialized cell based therapies. With product candidates in oncology and cardiology, Celyad seeks to address diseases with high unmet medical needs such as heart failure and cancer. Founded in 2007, Celyad leverages unique know-how in taking cell based therapies from bench to Phase III, as well as the manufacturing and logistical infrastructure for such complex products. Celyad builds it business model on partnering with prominent research institutions such as the Mayo Clinic and Dartmouth College, and develops those programs from bench to commercial applications.
Using data to connect patients to therapies that better benefit them.
We deliver high impact services through counseling, skill development, and crisis prevention to children, youth, adults and families.
Peer Direct is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Novadoz Pharmaceuticals is a sales and marketing subsidiary for MSN Labs portfolio of finished dosage forms. MSN Labs is a global leader in the development and manufacturing of APIs (active pharmaceutical ingredients).